ArticleDrugs in context2017

Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).

Neon Brooks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.